Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,003.05
    -68.58 (-1.35%)
     

  • Dow

    37,924.31
    -536.61 (-1.40%)
     

  • Nasdaq

    15,393.87
    -318.88 (-2.03%)
     

  • Bitcoin USD

    63,292.04
    -2,871.12 (-4.34%)
     

  • CMC Crypto 200

    1,346.04
    -36.53 (-2.64%)
     

  • FTSE 100

    8,051.39
    +11.01 (+0.14%)
     

  • Gold

    2,329.70
    -8.70 (-0.37%)
     

  • Crude Oil

    83.00
    +0.19 (+0.23%)
     

  • 10-Yr Bond

    4.7290
    +0.0770 (+1.66%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Stocks - Chewy, Altria Fall in Premarket; Stitch Fix, Autozone Rise

Investing.com
Updated

Investing.com -- Stocks in focus in premarket trade on Tuesday, 10th December.

Chewy (NYSE:CHWY) stock fell 2.4% after reporting a larger-than-expected loss per share of 20c, compared to expectations of 16c, in its quarterly report after the close on Monday.

Stitch Fix (NASDAQ:SFIX) stock rose 11% after the company defied expectations of a loss in the three months to November in earnings released after the close on Monday. The online personal-styling service also announced the appointment of Bain & Co. digital guru Elizabeth Spaulding as president.

AutoZone (NYSE:AZO) stock rose 5.7% in response to better-than-expected same-store sales in the three months to November.

ADVERTISEMENT

Amazon.com (NASDAQ:AMZN) stock edged 0.4% lower on general concerns about the economy, as the market continued to digest the news of its formal complaint about the way it lost a big-ticket order to provide the Defense Department with cloud-computing services.

Sanofi (PA:SASY) (NASDAQ:SNY) rose 4.5% after the company said it would drop expensive research into diabetes and cardiovascular drugs and squeeze some $2.2 billion a year in cost savings out of its supply chain.

Altria (NYSE:MO) stock fell 0.3%, extending losses on concerns about the valuation of its stake in Juul. Fellow investor Tiger Global has reportedly written its valuation of Juul down to $19 billion, whereas Altria still has a valuation of $24 billion on its books.

Related Articles

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.66%

Stitch Fix Spikes as Analysts See Upside From Direct Buy Program

Britain's Lloyds criticized for mistreating victims of major fraud